EXECUTIVE ENGAGEMENTS
OUTREACH
13417
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1612
Interactions with Platform & by Email
PARTICIPANTS
403
Unique # Participated
VALIDATIONS
181
Responses Validated*
COMPETITORS
46
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
63
PAGES
139
EDITION
9
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Biosurgery estimated at US$11.8 Billion in the year 2020, is projected to reach a revised size of US$16.7 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Surgical Sealing Agents, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hemostatic Agents segment is readjusted to a revised 5% CAGR for the next 7-year period.
The Biosurgery market in the U.S. is estimated at US$3.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
In the global Anti-Adhesion Agents segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$453.4 Million in the year 2020 will reach a projected size of US$661.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.9 Billion by the year 2027.
SELECT PLAYERS
B. Braun Melsungen AG; BARD, A Becton, Dickinson Company; Baxter International, Inc.; Cohera Medical, Inc.; CryoLife, Inc.; Hemostasis, LLC; Integra LifeSciences Holdings Corporation; Johnson & Johnson; MAQUET Holding B.V. & Co. KG; Medtronic PLC; Pfizer, Inc.; Sanofi U.S.; Stryker Corporation
SEGMENTS
» Product (Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management, Bone Graft Substitutes)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Biosurgery Market to Witness Steady Growth |
| Table: Percentage Market Share of Worldwide Bio-Surgeries by Country: 2015 and 2022 |
| Bone Graft Substitutes to Account for Largest Share |
| North American Region to Dominate Market Growth |
| Table: Worldwide Biosurgery Market: Breakdown of Total Sales Value (in Billion USD) by Region: 2015 and 2022 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| New Approvals to Support Market Growth |
| Various Strategies from Leading Players to Bolster Market Growth |
| Rapid Growth in Ageing Population Drives Market Growth |
| Table: Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E) |
| Rise in Worldwide Surgical Procedures to Fuel Market Growth |
| Table: Total Number of Surgical Procedures Performed (in Millions) Per Annum in the US: 1981-2015 |
| Table: Total Number of Surgical Procedures Performed for Inpatients in Europe per Annum: 2001-2015 |
| Rising Incidence of Injuries due to Trauma Supports Market Growth |
| Myriad Health End-Users to Drive Market Growth |
| Table: Percentage Breakdown of Biosurgery Market Shares by Application: 2018 |
| Table: Percentage Growth Rate of Various Bio-Surgical Products in Wound-Closure Segment: 2011-2017 |
| Innovations to Spur Market Growth |
| Table: Total Sales of DermaPure: 2016-2018 |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Soft Tissue Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Soft Tissue Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Soft Tissue Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 46 |
Is the U.S. Still a Better Global Barometer than China?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com